HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Öörni, K. Articles by Kovanen, P. T. Search for Related Content PubMed PubMed Citation Articles by Öörni, K. Articles by Kovanen, P. T. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 41, 1703-1714, November 2000
Copyright © 2000 by Lipid Research, Inc.

Review Article

Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions

Correspondence to: Petri T. Kovanen

Initiation of atherosclerosis is characterized by accumulation of aggregates of small lipid droplets and vesicles in the extracellular matrix of the arterial intima. The droplets and vesicles have features that suggest that they are formed from modified plasma-derived low density lipoprotein (LDL) particles. A variety of hydrolytic enzymes and prooxidative agents that could lead to extracellular assembly of LDL-derived droplets and vesicles are present in the arterial intima. In fact, in vitro studies have demonstrated that extensive oxidation of LDL and treatment of LDL with either proteolytic or lipolytic enzymes will induce LDL aggregation and fusion and treatment of LDL with cholesterol esterase will cause formation of vesicles. Fusion of LDL particles proceeds faster in vitro when they are bound to components of the extracellular matrix derived from the arterial intima, such as proteoglycans, and, depending on the type of modification, the strength of binding of modified LDL to the matrix components may either increase or decrease.

In the present article, we discuss molecular mechanisms that provide clues as to how aggregated lipid droplets and vesicles may be derived from modified LDL particles. We also describe how these modified forms of LDL, by means of their trapping to the extracellular matrix, may lead to extracellular lipid accumulation in the arterial intima. — Öörni, K., M. O. Pentikäinen, M. Ala-Korpela, and P. T. Kovanen. Aggregation, fusion, and vesicle formation of modified low density lipoprotein particles: molecular mechanisms and effects on matrix interactions. J. Lipid Res. 2000. 41: 1703;–1714.

Supplementary key words: proteolysis, oxidation, sphingomyelinase, phospholipase A₂, phospholipase C, cholesterol esterase, proteoglycans, lipoprotein lipase

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Bancells, S. Benitez, M. Jauhiainen, J. Ordonez-Llanos, P. T. Kovanen, S. Villegas, J. L. Sanchez-Quesada, and K. Oorni High binding affinity of electronegative LDL to human aortic proteoglycans depends on its aggregation level J. Lipid Res., March 1, 2009; 50(3): 446 - 455. [Abstract] [Full Text] [PDF]

				T. Parasassi, M. De Spirito, G. Mei, R. Brunelli, G. Greco, L. Lenzi, G. Maulucci, E. Nicolai, M. Papi, G. Arcovito, et al. Low density lipoprotein misfolding and amyloidogenesis FASEB J, July 1, 2008; 22(7): 2350 - 2356. [Abstract] [Full Text] [PDF]

				Y. Nakashima, T. N. Wight, and K. Sueishi Early atherosclerosis in humans: role of diffuse intimal thickening and extracellular matrix proteoglycans Cardiovasc Res, July 1, 2008; 79(1): 14 - 23. [Abstract] [Full Text] [PDF]

				I. Tabas, K. J. Williams, and J. Boren Subendothelial Lipoprotein Retention as the Initiating Process in Atherosclerosis: Update and Therapeutic Implications Circulation, October 16, 2007; 116(16): 1832 - 1844. [Abstract] [Full Text] [PDF]

				C. A. Gleissner, N. Leitinger, and K. Ley Effects of Native and Modified Low-Density Lipoproteins on Monocyte Recruitment in Atherosclerosis Hypertension, August 1, 2007; 50(2): 276 - 283. [Full Text] [PDF]

				T. Nagao, C. Qin, I. Grosheva, F. R. Maxfield, and L. M. Pierini Elevated Cholesterol Levels in the Plasma Membranes of Macrophages Inhibit Migration by Disrupting RhoA Regulation Arterioscler Thromb Vasc Biol, July 1, 2007; 27(7): 1596 - 1602. [Abstract] [Full Text] [PDF]

				H. J. Cho, P. Shashkin, C. A. Gleissner, D. Dunson, N. Jain, J. K. Lee, Y. Miller, and K. Ley Induction of dendritic cell-like phenotype in macrophages during foam cell formation Physiol Genomics, April 24, 2007; 29(2): 149 - 160. [Abstract] [Full Text] [PDF]

				K. Oorni and P. T. Kovanen PLA2-V: A Real Player in Atherogenesis Arterioscler Thromb Vasc Biol, March 1, 2007; 27(3): 445 - 447. [Full Text] [PDF]

				D. Namgaladze and B. Brune Phospholipase A2-Modified Low-Density Lipoprotein Activates the Phosphatidylinositol 3-Kinase-Akt Pathway and Increases Cell Survival in Monocytic Cells Arterioscler Thromb Vasc Biol, November 1, 2006; 26(11): 2510 - 2516. [Abstract] [Full Text] [PDF]

				M. Hashimoto, T. Kadowaki, T. Tsukuba, and K. Yamamoto Selective Proteolysis of Apolipoprotein B-100 by Arg-Gingipain Mediates Atherosclerosis Progression Accelerated by Bacterial Exposure J. Biochem., November 1, 2006; 140(5): 713 - 723. [Abstract] [Full Text] [PDF]

				M. Sneck, P. T. Kovanen, and K. Oorni Decrease in pH Strongly Enhances Binding of Native, Proteolyzed, Lipolyzed, and Oxidized Low Density Lipoprotein Particles to Human Aortic Proteoglycans J. Biol. Chem., November 11, 2005; 280(45): 37449 - 37454. [Abstract] [Full Text] [PDF]

				X. Zeng, J. Chen, Y. I. Miller, K. Javaherian, and K. S. Moulton Endostatin binds biglycan and LDL and interferes with LDL retention to the subendothelial matrix during atherosclerosis J. Lipid Res., September 1, 2005; 46(9): 1849 - 1859. [Abstract] [Full Text] [PDF]

				U. J. F. Tietge, D. Pratico, T. Ding, C. D. Funk, R. B. Hildebrand, T. Van Berkel, and M. Van Eck Macrophage-specific expression of group IIA sPLA2 results in accelerated atherogenesis by increasing oxidative stress J. Lipid Res., August 1, 2005; 46(8): 1604 - 1614. [Abstract] [Full Text] [PDF]

				K. Oorni, P. Posio, M. Ala-Korpela, M. Jauhiainen, and P. T. Kovanen Sphingomyelinase Induces Aggregation and Fusion of Small Very Low-Density Lipoprotein and Intermediate-Density Lipoprotein Particles and Increases Their Retention to Human Arterial Proteoglycans Arterioscler Thromb Vasc Biol, August 1, 2005; 25(8): 1678 - 1683. [Abstract] [Full Text] [PDF]

				R. Asmis, J. G. Begley, J. Jelk, and W. V. Everson Lipoprotein aggregation protects human monocyte-derived macrophages from OxLDL-induced cytotoxicity J. Lipid Res., June 1, 2005; 46(6): 1124 - 1132. [Abstract] [Full Text] [PDF]

				S. M. Boekholdt, T. T. Keller, N. J. Wareham, R. Luben, S. A. Bingham, N. E. Day, M. S. Sandhu, J. W. Jukema, J. J.P. Kastelein, C. E. Hack, et al. Serum Levels of Type II Secretory Phospholipase A2 and the Risk of Future Coronary Artery Disease in Apparently Healthy Men and Women: The EPIC-Norfolk Prospective Population Study Arterioscler Thromb Vasc Biol, April 1, 2005; 25(4): 839 - 846. [Abstract] [Full Text] [PDF]

				L. Asatryan, R. T. Hamilton, J. M. Isas, J. Hwang, R. Kayed, and A. Sevanian LDL phospholipid hydrolysis produces modified electronegative particles with an unfolded apoB-100 protein J. Lipid Res., January 1, 2005; 46(1): 115 - 122. [Abstract] [Full Text] [PDF]

				K. Oorni, M. Sneck, D. Bromme, M. O. Pentikainen, K. A. Lindstedt, M. Mayranpaa, H. Aitio, and P. T. Kovanen Cysteine Protease Cathepsin F Is Expressed in Human Atherosclerotic Lesions, Is Secreted by Cultured Macrophages, and Modifies Low Density Lipoprotein Particles in Vitro J. Biol. Chem., August 13, 2004; 279(33): 34776 - 34784. [Abstract] [Full Text] [PDF]

				S.-y. Morita, M. Kawabe, A. Sakurai, K. Okuhira, A. Vertut-Doi, M. Nakano, and T. Handa Ceramide in Lipid Particles Enhances Heparan Sulfate Proteoglycan and Low Density Lipoprotein Receptor-related Protein-mediated Uptake by Macrophages J. Biol. Chem., June 4, 2004; 279(23): 24355 - 24361. [Abstract] [Full Text] [PDF]

				C. R. Wooton-Kee, B. B. Boyanovsky, M. S. Nasser, W. J.S. de Villiers, and N. R. Webb Group V sPLA2 Hydrolysis of Low-Density Lipoprotein Results in Spontaneous Particle Aggregation and Promotes Macrophage Foam Cell Formation Arterioscler Thromb Vasc Biol, April 1, 2004; 24(4): 762 - 767. [Abstract] [Full Text] [PDF]

				G. Malek, C.-M. Li, C. Guidry, N. E. Medeiros, and C. A. Curcio Apolipoprotein B in Cholesterol-Containing Drusen and Basal Deposits of Human Eyes with Age-Related Maculopathy Am. J. Pathol., February 1, 2003; 162(2): 413 - 425. [Abstract] [Full Text] [PDF]

				M. O. Pentikainen, R. Oksjoki, K. Oorni, and P. T. Kovanen Lipoprotein Lipase in the Arterial Wall: Linking LDL to the Arterial Extracellular Matrix and Much More Arterioscler Thromb Vasc Biol, February 1, 2002; 22(2): 211 - 217. [Abstract] [Full Text] [PDF]

				J. Nilsson, M.P.S. Ares, M. Lindholm, G.N. Fredriksonl, and S. Jovinge Inflammation and cholesterol Eur. Heart J. Suppl., February 1, 2002; 4(suppl_A): A18 - A25. [Abstract] [PDF]

				C. Edelstein, K. Nakajima, D. Pfaffinger, and A. M. Scanu Oxidative events cause degradation of apoB-100 but not of apo[a] and facilitate enzymatic cleavage of both proteins J. Lipid Res., October 1, 2001; 42(10): 1664 - 1670. [Abstract] [Full Text] [PDF]

				E. Hurt-Camejo, G. Camejo, H. Peilot, K. Oorni, and P. Kovanen Phospholipase A2 in Vascular Disease Circ. Res., August 17, 2001; 89(4): 298 - 304. [Abstract] [Full Text] [PDF]

				M. O. Pentikäinen, M. T. Hyvönen, K. Öörni, T. Hevonoja, A. Korhonen, E. M. P. Lehtonen-Smeds, M. Ala-Korpela, and P. T. Kovanen Altered phospholipid-apoB-100 interactions and generation of extra membrane material in proteolysis-induced fusion of LDL particles J. Lipid Res., June 1, 2001; 42(6): 916 - 922. [Abstract] [Full Text]

				J. K. Hakala, K. Oorni, M. O. Pentikainen, E. Hurt-Camejo, and P. T. Kovanen Lipolysis of LDL by Human Secretory Phospholipase A2 Induces Particle Fusion and Enhances the Retention of LDL to Human Aortic Proteoglycans Arterioscler Thromb Vasc Biol, June 1, 2001; 21(6): 1053 - 1058. [Abstract] [Full Text] [PDF]